Acta Cytol

1. UCAK R, Dilbaz OF, Polat N
   Analysis of the Differences between Bethesda Groups according to Conventional Smear and Liquid-Based Cytology Methods in Cervicovaginal Cytology: A Single-Center Experience with 165,915 Cases.
   Acta Cytol. 2024;68:54-59.
   

   >> Share

   
   

   
   Acta Obstet Gynecol Scand

2. FOTHERINGHAM P, Safi N, Li Z, Anazodo A, et al
   Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study.
   Acta Obstet Gynecol Scand. 2023 Mar 13. doi: 10.1111/aogs.14530.
   

   >> Share

   
   
3. HARRIS CA, Mandelbaum RS, Rau AR, Song BB, et al
   Contraception and sterilization selection at delivery among pregnant patients with malignancy.
   Acta Obstet Gynecol Scand. 2023 Aug 14. doi: 10.1111/aogs.14654.
   

   >> Share

   
   
4. BOHLIN KS, Brannstrom M, Dahm-Kahler P
   Gynecological cancer during pregnancy-From a gyne-oncological perspective.
   Acta Obstet Gynecol Scand. 2024 Jan 6. doi: 10.1111/aogs.14763.
   

   >> Share

   
   

   
   Am Fam Physician

5. ESPINOSA K
   ASCCP Management Guidelines for Abnormal Cervical Cancer Screening.
   Am Fam Physician. 2024;109:275-276.
   

   >> Share

   
   

   
   Am J Clin Oncol

6. SAUVAGE LM, Bentahila R, Tran Y, Guenegou-Arnoux A, et al
   Radiation Proctitis in Patients With Locally Advanced Cervical Cancer Treated by Chemoradiation: Analysis and Predictive Factors From a Retrospective Cohort.
   Am J Clin Oncol. 2024 Apr 1. doi: 10.1097/COC.0000000000001092.
   

   >> Share

   
   

   
   Am J Clin Pathol

7. ALQABBANI R, Chan J, Goldberg A
   Presence of 10 transformation zone cells in endocervical curettage should not be required for adequacy.
   Am J Clin Pathol. 2024;161:369-373.
   

   >> Share

   
   

   
   Am J Obstet Gynecol

8. KROG L, Lycke KD, Kahlert J, Randrup TH, et al
   Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study.
   Am J Obstet Gynecol. 2024;230:430.
   

   >> Share

   
   

   
   Anal Methods

9. XIAO H, Chen W, Lin M, Jiang S, et al
   Rapid immunoassay for dual-mode detection of HPV16 and HPV18 DNA based on Au@PdPt nanoparticles.
   Anal Methods. 2024;16:1862-1869.
   

   >> Share

   
   

   
   Ann Intern Med

10. BATUR P
    For due or overdue cervical cancer screening, direct or opt-in mailing of HPV self-sampling increased screening at 6 mo vs. education.
    Ann Intern Med. 2024 Apr 2. doi: 10.7326/J24-0019.
    

    >> Share

    
    

    
    Arch Biochem Biophys

11. ZOU T, Gao Y, Qie M
    Promotive actions of lncRNA EBLN3P involved in cervical cancer progression via interacting with miR-29c-3p and TAF15 to modify RCC2.
    Arch Biochem Biophys. 2024 Mar 28:109980. doi: 10.1016/j.abb.2024.109980.
    

    >> Share

    
    
12. WANG Q, Wang B, Zhang W, Zhang T, et al
    APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway.
    Arch Biochem Biophys. 2024;755:109983.
    

    >> Share

    
    

    
    BMC Cancer

13. LI Z, Zhou G, Jiang L, Wang M, et al
    Analysis of related factors for pathological upgrading of cervical biopsy from CIN3 to cancer after conical resection.
    BMC Cancer. 2024;24:401.
    

    >> Share

    
    

    
    BMC Health Serv Res

14. OKYERE J, Ayebeng C, Dickson KS
    Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25-49 years: evidence from the 2021 Cote d'Ivoire demographic and health survey.
    BMC Health Serv Res. 2024;24:423.
    

    >> Share

    
    

    
    BMC Infect Dis

15. SIMUYEMBA MC, Chama-Chiliba CM, Chompolola A, Sinyangwe A, et al
    An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia.
    BMC Infect Dis. 2024;24:369.
    

    >> Share

    
    

    
    BMC Womens Health

16. NGABONZIZA E, Ghebre R, DeBoer RJ, Ntasumbumuyange D, et al
    Outcomes of neoadjuvant chemotherapy and radical hysterectomy for locally advanced cervical cancer at Kigali University Teaching Hospital, Rwanda: a retrospective descriptive study.
    BMC Womens Health. 2024;24:204.
    

    >> Share

    
    
17. SEYFU DT, Abebe SN, Haile S, Ayana BA, et al
    Health related quality of life and its predictive factors on cervical cancer patients in two teaching hospitals, Addis Ababa, Ethiopia.
    BMC Womens Health. 2024;24:209.
    

    >> Share

    
    

    
    BMJ Case Rep

18. BAHADUR A, Mundhra R, Gill P, Singh A, et al
    Aggressive precursor B cell ALL of cervix with obstructive uropathy.
    BMJ Case Rep. 2024;17:e258313.
    

    >> Share

    
    

    
    BMJ Open

19. ZHENG S, Zhang X, Greuter MJW, de Bock GH, et al
    Willingness of healthcare providers to perform population-based cancer screening: a cross-sectional study in primary healthcare institutions in Tianjin, China.
    BMJ Open. 2024;14:e075604.
    

    >> Share

    
    

    
    Brachytherapy

20. LADBURY C, Eustace N, Kassardjian A, Amini A, et al
    Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era.
    Brachytherapy. 2024 Mar 28:S1538-4721(24)00010.
    

    >> Share

    
    

    
    Cancer Control

21. EFFAH K, Anthony R, Tekpor E, Amuah JE, et al
    HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
    Cancer Control. 2024;31:10732748241244678.
    

    >> Share

    
    

    
    Clin Epigenetics

22. CHEN D, Cai B, Zhu Y, Ma Y, et al
    Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer.
    Clin Epigenetics. 2024;16:51.
    

    >> Share

    
    

    
    Cureus

23. NAGAI H
    Immunoradiation Therapy for End-Stage Undifferentiated Cervical Cancer That Restored Sensitivity to Chemotherapy and Resulted in the Disappearance of the Cancer.
    Cureus. 2024;16:e57144.
    

    >> Share

    
    
24. YAMADA S, Fukugawa Y, Otsuka T, Saito T, et al
    Radiation-Induced Myonecrosis: A Case Report of a Cervical Cancer Patient With a History of Systemic Lupus Erythematosus.
    Cureus. 2024;16:e55134.
    

    >> Share

    
    

    
    Discov Oncol

25. LI X, Zhang L, Huang X, Peng Q, et al
    High-throughput metabolomics identifies new biomarkers for cervical cancer.
    Discov Oncol. 2024;15:90.
    

    >> Share

    
    

    
    Ecancermedicalscience

26. ROCHA NSS, Clara BM, Luz LMM, do Rosario Oliveira Martins M, et al
    Knowledge, attitudes and practices of cervical cancer screening among female students enrolled in higher education institutions in Cabo Verde.
    Ecancermedicalscience. 2024;18:1689.
    

    >> Share

    
    

    
    Environ Toxicol

27. MA Y, Zhu W
    Development of gene panel for predicting recurrence in early-stage cervical cancer patients.
    Environ Toxicol. 2024 Apr 2. doi: 10.1002/tox.24270.
    

    >> Share

    
    

    
    Eur J Public Health

28. PARTANEN VM, Dillner J, Trope A, Agustsson AI, et al
    Divergent effects of switching from cytology to HPV-based screening in the Nordic countries.
    Eur J Public Health. 2024;34:354-360.
    

    >> Share

    
    
29. NGO O, Chloupkova R, Cibula D, Slama J, et al
    Direct mailing of HPV self-sampling kits to women aged 50-65 non-participating in cervical screening in the Czech Republic.
    Eur J Public Health. 2024;34:361-367.
    

    >> Share

    
    

    
    Eur J Surg Oncol

30. CHEN X, Duan H, Zhao H, He F, et al
    Perineural invasion in cervical cancer: A multicenter retrospective study.
    Eur J Surg Oncol. 2024;50:108313.
    

    >> Share

    
    
31. TIAN X, Liu P, Kang S, Cui Z, et al
    Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
    Eur J Surg Oncol. 2024;50:107977.
    

    >> Share

    
    
32. DITTO A, Longo M, Chiarello G, Mariani L, et al
    Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer?
    Eur J Surg Oncol. 2024;50:108311.
    

    >> Share

    
    

    
    Exp Cell Res

33. YOSHIMOTO M, Tokuda A, Eguchi A, Nozawa Y, et al
    Alterations of UHRF family Expression and was regulated by High Risk Type HPV16 in Uterine Cervical Cancer.
    Exp Cell Res. 2024;437:114018.
    

    >> Share

    
    

    
    Front Immunol

34. LIANG KW, Chen LJ, Wang CH, Ma KS, et al
    Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis.
    Front Immunol. 2024;15:1331994.
    

    >> Share

    
    

    
    Front Oncol

35. CORDOBA A, Gesta E, Escande A, Noeuveglise A, et al
    Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons.
    Front Oncol. 2024;14:1347727.
    

    >> Share

    
    
36. VALLEJO-RUIZ V, Gutierrez-Xicotencatl L, Medina-Contreras O, Lizano M, et al
    Molecular aspects of cervical cancer: a pathogenesis update.
    Front Oncol. 2024;14:1356581.
    

    >> Share

    
    
37. SONG X, Li X, Tan Z, Zhang L, et al
    Corrigendum: Recent status and trends of nanotechnology in cervical cancer: a systematic review and bibliometric analysis.
    Front Oncol. 2024;14:1395166.
    

    >> Share

    
    
38. WANG J, Guo H, Yang J, Mao J, et al
    Efficacy and safety of consolidation chemotherapy after adjuvant therapy in stage IB-IIA cervical cancer patients with risk factors: a retrospective single-center study.
    Front Oncol. 2024;14:1374195.
    

    >> Share

    
    

    
    Front Public Health

39. GAZZETTA S, Valent F, Sala A, Driul L, et al
    Sexually transmitted infections and the HPV-related burden: evolution of Italian epidemiology and policy.
    Front Public Health. 2024;12:1336250.
    

    >> Share

    
    
40. RODRIGUES IO, Duarte I, Costa CG, Pimentel AL, et al
    Knowledge about cervical cancer in young Portuguese women: a cross-sectional study.
    Front Public Health. 2024;12:1357606.
    

    >> Share

    
    

    
    Gynecol Oncol

41. VESZTERGOM D, Teglas G, Bahrehmand K, Torok A, et al
    Reducing radicality in fertility-sparing surgery is associated with improved in vitro fertilization outcome in early-stage cervical cancer: A national retrospective study.
    Gynecol Oncol. 2024;186:35-41.
    

    >> Share

    
    

    
    Health Expect

42. GOSSE RA, Msengi EA, Chona EZ, Ambikile JS, et al
    Experiences of caring for women with cervical cancer: A qualitative study among male partners in Dar es Salaam, Tanzania.
    Health Expect. 2024;27:e14038.
    

    >> Share

    
    

    
    Hum Vaccin Immunother

43. LIU P, Yang X, Zhao H, Liang L, et al
    High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies.
    Hum Vaccin Immunother. 2024;20:2337161.
    

    >> Share

    
    

    
    Implement Sci Commun

44. GILMAN SD, Gravitt PE, Paz-Soldan VA
    Implementation of new technologies designed to improve cervical cancer screening and completion of care in low-resource settings: a case study from the Proyecto Precancer.
    Implement Sci Commun. 2024;5:35.
    

    >> Share

    
    

    
    Int J Gynecol Cancer

45. HANEY K, Ismail-Pratt I, Ng JS, Schmeler KM, et al
    The International Gynecologic Cancer Society Preinvasive Certificate Program: building a skilled workforce for the detection and treatment of cervical pre-cancer.
    Int J Gynecol Cancer. 2024;34:637-638.
    

    >> Share

    
    
46. KEMAH BL, Bhagat N, Pandya A, Sullivan R, et al
    Training the gynecologic oncologists of the future - challenges and opportunities.
    Int J Gynecol Cancer. 2024;34:619-626.
    

    >> Share

    
    

    
    J Am Coll Health

47. YAHIA A, Cole E, Rayford A, Fava J, et al
    A community-based, interdisciplinary approach to improving HPV vaccine uptake at a large urban public university.
    J Am Coll Health. 2024;72:500-508.
    

    >> Share

    
    

    
    J Cancer Res Ther

48. ANAND A, Raju K
    Significance of platelet parameters in invasive squamous cell carcinoma of uterine cervix.
    J Cancer Res Ther. 2024;20:139-143.
    

    >> Share

    
    

    
    J Cell Physiol

49. LI N, Wang XL, Ge R, Wang Y, et al
    FNDC5 inhibits malignant growth of human cervical cancer cells via restraining PI3K/AKT pathway.
    J Cell Physiol. 2024 Apr 1. doi: 10.1002/jcp.31267.
    

    >> Share

    
    

    
    J Educ Health Promot

50. DIVYA KT, Chidrawar VR, Bhupalam PK, Shiromwar S, et al
    Assessment of knowledge and attitude of cervical cancer among the youths in the Rayalaseema region of Andhra Pradesh - India.
    J Educ Health Promot. 2024;13:73.
    

    >> Share

    
    

    
    J Gynecol Obstet Hum Reprod

51. YANG L, Bu G, Zhao J, La X, et al
    Comparison of 3D and 2D laparoscopy: Initial experience of perioperative outcomes and clinical assessment.
    J Gynecol Obstet Hum Reprod. 2024;53:102754.
    

    >> Share

    
    

    
    J Int Med Res

52. GUO X, Zhao E, Guan Z, Li W, et al
    A retrospective study of the effects of uterine manipulators on prognosis in patients with cervical cancer.
    J Int Med Res. 2024;52:3000605241233966.
    

    >> Share

    
    

    
    J Med Virol

53. HUSEINOVIC A, Xu M, Jaspers A, Bais B, et al
    miR-129-5p inhibits anchorage-independent growth through silencing of ACTN1 and the ELK4/c-FOS axis in HPV-transformed keratinocytes.
    J Med Virol. 2024;96:e29580.
    

    >> Share

    
    
54. ARVIZU-HERNANDEZ E, Hernandez-Guerrero CJ, Alvarez-Rios E, Gariglio P, et al
    Laurencia johnstonii extract reverses early lesions in the K14E7HPV16 murine cervical carcinogenesis model.
    J Med Virol. 2024;96:e29571.
    

    >> Share

    
    

    
    J Natl Compr Canc Netw

55. TERGAS A, Byron S, Zhang G, Izatt T, et al
    YIA24-007: Genetic Ancestry and Genomic Alterations of Cervical Cancer in a Diverse Patient Population.
    J Natl Compr Canc Netw. 2024;22.
    

    >> Share

    
    

    
    J Obstet Gynaecol Res

56. SAKURAI A, Yamanoi K, Yamaguchi K, Hamanishi J, et al
    Neuroendocrine carcinoma of the uterine cervix with extensive pagetoid spread pattern.
    J Obstet Gynaecol Res. 2024;50:758-763.
    

    >> Share

    
    
57. LI F, Chen A, Shan Y, Yao Y, et al
    Factors associated with human papillomavirus persistence after loop electrosurgical excision procedure in patients with cervical squamous intraepithelial lesion.
    J Obstet Gynaecol Res. 2024;50:639-646.
    

    >> Share

    
    

    
    J Trace Elem Med Biol

58. YIN Q, Zhou Q, Hu J, Weng J, et al
    Fabrication of bimetallic Ag@ZnO nanocomposite and its anti-cancer activity on cervical cancer via impeding PI3K/AKT/mTOR pathway.
    J Trace Elem Med Biol. 2024;84:127437.
    

    >> Share

    
    

    
    J West Afr Coll Surg

59. ANYAKA CU, Alero BJ, Olukoya B, Envuladu EA, et al
    Parental Knowledge of HPV Infection, Cervical Cancer and the Acceptance of HPV Vaccination for their Children in Jos, Nigeria.
    J West Afr Coll Surg. 2024;14:146-153.
    

    >> Share

    
    

    
    JAMA Netw Open

60. WANG S, Dang L, Liu S, Rezhake R, et al
    Cervical Cancer Screening via Visual Inspection With Acetic Acid and Lugol Iodine for Triage of HPV-Positive Women.
    JAMA Netw Open. 2024;7:e244090.
    

    >> Share

    
    

    
    Jpn J Radiol

61. PARISI S, Sciacca M, Ferrantelli G, Chillari F, et al
    Locally advanced squamous cervical carcinoma (M0): management and emerging therapeutic options in the precision radiotherapy era.
    Jpn J Radiol. 2024;42:354-366.
    

    >> Share

    
    

    
    Medicine (Baltimore)

62. SU D, Song X, Wu F, Fan S, et al
    Cervical clear cell carcinoma: Case report and literature review.
    Medicine (Baltimore). 2024;103:e37449.
    

    >> Share

    
    
63. KONG Y, Liu S, Wang X, Qie R, et al
    Associations between gut microbiota and gynecological cancers: A bi-directional two-sample Mendelian randomization study.
    Medicine (Baltimore). 2024;103:e37628.
    

    >> Share

    
    
64. LI M, Zheng W
    Mature solid teratoma of the uterine cervix: A rare case report and review of the literature.
    Medicine (Baltimore). 2024;103:e37451.
    

    >> Share

    
    

    
    Mol Biotechnol

65. ASWATHY R, Sumathi S
    The Evolving Landscape of Cervical Cancer: Breakthroughs in Screening and Therapy Through Integrating Biotechnology and Artificial Intelligence.
    Mol Biotechnol. 2024 Apr 4. doi: 10.1007/s12033-024-01124.
    

    >> Share

    
    

    
    Nat Rev Clin Oncol

66. SIDAWAY P
    Pembrolizumab plus chemoradiotherapy effective in locally advanced cervical cancer.
    Nat Rev Clin Oncol. 2024 Apr 2. doi: 10.1038/s41571-024-00889.
    

    >> Share

    
    

    
    Noncoding RNA Res

67. NAIK D, Kalle AM
    MicroRNA-mediated epigenetic regulation of HDAC8 and HDAC6: Functional significance in cervical cancer.
    Noncoding RNA Res. 2024;9:732-743.
    

    >> Share

    
    

    
    PLoS One

68. OOMMEN AM, Isaac R, Paul B, Weller D, et al
    Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.
    PLoS One. 2024;19:e0301385.
    

    >> Share

    
    

    
    Radiother Oncol

69. SKIPAR K, Hompland T, Lund KV, Lindemann K, et al
    Mri-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy.
    Radiother Oncol. 2024 Mar 29:110263. doi: 10.1016/j.radonc.2024.110263.
    

    >> Share

    
    

    
    Sci Rep

70. ZENG S, Yang P, Xiao S, Liu L, et al
    Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study.
    Sci Rep. 2024;14:7681.
    

    >> Share

    
    

    
    Toxicology

71. KHAN NG, Adiga D, Rai PS, Kabekkodu SP, et al
    Integrated In-Silico and In Vitro analysis to Decipher the contribution of bisphenol-A in cervical cancer.
    Toxicology. 2024;504:153791.
    

    >> Share

    
    

    
    Urol Int

72. AKSOY C, Reimold P, Schumann A, Schneidewind L, et al
    Enhancing Human Papillomavirus Vaccination Rates through Better Knowledge? Insights from a Survey among German Medical Students.
    Urol Int. 2024;108:153-158.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share